These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6379146)

  • 1. Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.
    Hirayama H; Kasuya Y; Kobayashi T; Itoh T; Yagishita A; Katakura T; Isono K
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):595-609. PubMed ID: 6379146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs.
    Shi ZQ; Giacca A; Yamatani K; Fisher SJ; Lickley HL; Vranic M
    Am J Physiol; 1993 Mar; 264(3 Pt 1):E334-41. PubMed ID: 8460681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Bolie model describing blood glucose response for the application to continuous subcutaneous insulin infusion.
    Hirayama H; Kasuya Y; Yagishita A; Katakura T
    J Pharmacobiodyn; 1985 Oct; 8(10):808-18. PubMed ID: 3912487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
    Valverde I; Dobbs R; Unger RH
    Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exogenously administered glucagon on plasma glucose levels in totally depancreatized dogs.
    Nishimura I; Sudo T; Konishi K; Suzuki T; Tobe T; Nakagawa M; Nakase A
    Gastroenterol Jpn; 1978; 13(6):468-79. PubMed ID: 748092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose.
    Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C
    Metabolism; 1981 May; 30(5):439-42. PubMed ID: 6112654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man.
    Waldhäusl WK; Bratusch-Marrain PR; Vierhapper H; Nowotny P
    Metabolism; 1983 May; 32(5):478-86. PubMed ID: 6341763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of glucose tolerance and insulin response in partially depancreatized dogs.
    Sun AM; Coddling JA; Haist RE
    Diabetes; 1974 May; 23(5):424-32. PubMed ID: 4598091
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced bioavailability of insulin after rectal administration with enamine as adjuvant in depancreatized dogs.
    Nishihata T; Okamura Y; Kamada A; Higuchi T; Yagi T; Kawamori R; Shichiri M
    J Pharm Pharmacol; 1985 Jan; 37(1):22-6. PubMed ID: 2858523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.
    Kraegen EW; Chisholm DJ
    Clin Pharmacokinet; 1985; 10(4):303-14. PubMed ID: 3899451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies.
    Kraegen EW; Chisholm DJ
    Diabetologia; 1984 Mar; 26(3):208-13. PubMed ID: 6370771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dynamic property of glucagon secretion in response to blood glucose--analysis with the aid of the control theory using an artificial endocrine pancreas].
    Yagi T
    Nihon Naibunpi Gakkai Zasshi; 1985 Feb; 61(2):69-79. PubMed ID: 3891432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
    Colca JR; Hazelwood RL
    J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.
    Giacca A; Fisher SJ; Shi ZQ; Gupta R; Lickley HL; Vranic M
    J Clin Invest; 1992 Nov; 90(5):1769-77. PubMed ID: 1430203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.
    Watanabe RM; Vølund A; Bergman RN
    Diabetes Care; 1991 Nov; 14(11):1021-30. PubMed ID: 1797482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.